Genzyme shares hit 52-week high
March 08, 2011 at 12:07 PM EST
Stock touches high after board recommends shareholders take Sanofi Aventis $74-a-share offer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.